(Q42205083)

18 October 2017

GMCSF-armed vaccinia virus induces an antitumor immune response (English)

1 reference

18 October 2017

vaccinia virus

1 reference

6

Markus Vähä-Koskela

1 reference

18 October 2017

9

Akseli Hemminki

1 reference

18 October 2017

3

Iulia Diaconu

1 reference

18 October 2017

7

Anna Kanerva

1 reference

18 October 2017

Suvi Parviainen

1

1 reference

18 October 2017

Marko Ahonen

2

1 reference

18 October 2017

Anja Kipar

4

1 reference

18 October 2017

Mikko Siurala

5

1 reference

18 October 2017

Vincenzo Cerullo

8

1 reference

18 October 2017

language of work or name

English

0 references

publication date

10 July 2014

1 reference

International Journal of Cancer

18 October 2017

1 reference

18 October 2017

136

1 reference

18 October 2017

5

1 reference

18 October 2017

1065-1072

1 reference

Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers

18 October 2017

1 reference

Oncolytic vaccinia virus for the treatment of cancer

21 January 2018

1 reference

Fighting cancer with vaccinia virus: teaching new tricks to an old dog.

21 January 2018

1 reference

Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer models

21 January 2018

1 reference

CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging

21 January 2018

1 reference

Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963

21 January 2018

1 reference

Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer

21 January 2018

1 reference

Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma

21 January 2018

1 reference

Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer

21 January 2018

1 reference

Oncolytic viruses: a novel form of immunotherapy

21 January 2018

1 reference

Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients

21 January 2018

1 reference

Chapter eight--Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humans

21 January 2018

1 reference

From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer

21 January 2018

1 reference

GM-CSF-secreting melanoma vaccines

21 January 2018

1 reference

Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF.

21 January 2018

1 reference

Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus

21 January 2018

1 reference

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial

21 January 2018

1 reference

Myeloid derived suppressor cells and their role in diseases.

21 January 2018

1 reference

A novel therapeutic regimen to eradicate established solid tumors with an effective induction of tumor-specific immunity.

21 January 2018

1 reference

Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.

21 January 2018

1 reference

The HaP-T1 Syrian golden hamster pancreatic cancer model: cell implantation is better than tissue implantation

21 January 2018

1 reference

Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein

21 January 2018

1 reference

In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus responders

21 January 2018

1 reference

Noninvasive optical tracking of red fluorescent protein-expressing cancer cells in a model of metastatic breast cancer

21 January 2018

1 reference

Improving the photostability of bright monomeric orange and red fluorescent proteins

21 January 2018

1 reference

Identification of splenic reservoir monocytes and their deployment to inflammatory sites

21 January 2018

1 reference

The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.29068

1 reference

release_rtlslimzarcbhb6u4u5ba74paq

18 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rtlslimzarcbhb6u4u5ba74paq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference